Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 2
1986 2
1988 1
1989 2
1992 3
1993 1
1996 3
2000 2
2001 2
2002 3
2003 1
2005 2
2006 3
2007 1
2010 5
2011 5
2012 4
2013 8
2014 7
2015 4
2016 7
2017 6
2018 8
2019 16
2020 38
2021 30
2022 17
2023 13
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

179 results

Results by year

Filters applied: . Clear all
Page 1
BRAF Inhibitors: Molecular Targeting and Immunomodulatory Actions.
Proietti I, Skroza N, Michelini S, Mambrin A, Balduzzi V, Bernardini N, Marchesiello A, Tolino E, Volpe S, Maddalena P, Di Fraia M, Mangino G, Romeo G, Potenza C. Proietti I, et al. Among authors: potenza c. Cancers (Basel). 2020 Jul 7;12(7):1823. doi: 10.3390/cancers12071823. Cancers (Basel). 2020. PMID: 32645969 Free PMC article. Review.
Aesthetic Treatments in Cancer Patients.
Proietti I, Skroza N, Mambrin A, Marraffa F, Tolino E, Bernardini N, Marchesiello A, Rossi G, Volpe S, Potenza C. Proietti I, et al. Among authors: potenza c. Clin Cosmet Investig Dermatol. 2021 Dec 4;14:1831-1837. doi: 10.2147/CCID.S342734. eCollection 2021. Clin Cosmet Investig Dermatol. 2021. PMID: 34898993 Free PMC article.
A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years.
Patruno C, Fabbrocini G, Lauletta G, Boccaletti V, Colonna C, Cavalli R, Neri I, Ortoncelli M, Schena D, Stingeni L, Hansel K, Piccolo V, Di Brizzi V, Potenza C, Tolino E, Bianchi L, Manti S, De Pasquale R, Di Lernia V, Caminiti L, Galli E, Coppo P, Chiricozzi A, De Simone C, Guerriero C, Amoruso FG, Provenzano E, Leonardi S, Licari A, Marseglia GL, Palermo A, Di Pillo S, Russo D, Moschese V, Patella V, Peduto T, Ferreli C, Zangari P, Veronese F, Berti SF, Gruber M, Pezzolo E, Termine S, Satta R, Dragoni F, Esposito M, Fargnoli MC, Chiodini P, Vallone Y, di Vico F, Picone V, Napolitano M. Patruno C, et al. Among authors: potenza c. J Dermatolog Treat. 2023 Dec;34(1):2246602. doi: 10.1080/09546634.2023.2246602. J Dermatolog Treat. 2023. PMID: 37580895 Free article.
The Skin in Celiac Disease Patients: The Other Side of the Coin.
Abenavoli L, Dastoli S, Bennardo L, Boccuto L, Passante M, Silvestri M, Proietti I, Potenza C, Luzza F, Nisticò SP. Abenavoli L, et al. Among authors: potenza c. Medicina (Kaunas). 2019 Sep 9;55(9):578. doi: 10.3390/medicina55090578. Medicina (Kaunas). 2019. PMID: 31505858 Free PMC article. Review.
HIV positive patient treated with ixekizumab.
Bernardini N, Skroza N, Tolino E, Marchesiello A, Mambrin A, Balduzzi V, Michelini S, Maddalena P, Volpe S, Proietti I, Potenza C. Bernardini N, et al. Among authors: potenza c. Clin Ter. 2022 May 25;173(3):195-197. doi: 10.7417/CT.2022.2416. Clin Ter. 2022. PMID: 35612328 Free article.
Postacne scarring: which factors are involved?
Tolino E, Skroza N, Proietti I, Bernardini N, Balduzzi V, Anzalone A, LA Torre G, Marchesiello A, Mambrin A, Potenza C. Tolino E, et al. Among authors: potenza c. G Ital Dermatol Venereol. 2020 Dec;155(6):793-794. doi: 10.23736/S0392-0488.19.06154-6. Epub 2019 Jul 12. G Ital Dermatol Venereol. 2020. PMID: 31302974 No abstract available.
Women and acne: any difference from males? A review of the literature.
Skroza N, Tolino E, Proietti I, Bernardini N, La Viola G, Nicolucci F, Pampena R, Zuber S, Balduzzi V, Soccodato V, Mancini MT, Potenza C. Skroza N, et al. Among authors: potenza c. G Ital Dermatol Venereol. 2016 Feb;151(1):87-92. Epub 2014 Sep 18. G Ital Dermatol Venereol. 2016. PMID: 25236316 Review.
Analysis of predictive factors influencing dupilumab continuation rate in adult patients with atopic dermatitis: results from an Italian multicenter study.
Gori N, Sernicola A, Tolino E, Mariano M, Galluzzo M, Moretta G, Coppola R, D'Alessio A, Sansone M, Maffei V, Paolino C, Ferrao C, Cascia L, Addio P, Di Nardo L, Chiricozzi A, Del Duca E, Cristaudo A, Bianchi L, Pallotta S, Panasiti V, Pellacani G, Potenza C, Peris K. Gori N, et al. Among authors: potenza c. J Dermatolog Treat. 2023 Dec;34(1):2230685. doi: 10.1080/09546634.2023.2230685. J Dermatolog Treat. 2023. PMID: 37400981 Free article.
Correlations between psoriasis and inflammatory bowel diseases.
Skroza N, Proietti I, Pampena R, La Viola G, Bernardini N, Nicolucci F, Tolino E, Zuber S, Soccodato V, Potenza C. Skroza N, et al. Among authors: potenza c. Biomed Res Int. 2013;2013:983902. doi: 10.1155/2013/983902. Epub 2013 Jul 21. Biomed Res Int. 2013. PMID: 23971052 Free PMC article. Review.
External Validation of the IHS4-55 in a European Antibiotic-Treated Hidradenitis Suppurativa Cohort.
van Straalen KR, Tzellos T, Alavi A, Benhadou F, Cuenca-Barrales C, Daxhelet M, Daoud M, Efthymiou O, Giamarellos-Bourboulis EJ, Guillem P, Gulliver W, Jemec GBE, Katoulis A, Koenig A, Lazaridou E, Lowes MA, Marzano AV, Matusiak L, Molina-Leyva A, Moltrasio C, Pinter A, Potenza C, Prens EP, Romaní J, Saunte DM, Sayed C, Skroza N, Stergianou D, Szepietowski JC, Trigoni A, Vilarrasa E, Kyrgidis A, Zouboulis CC, van der Zee HH. van Straalen KR, et al. Among authors: potenza c. Dermatology. 2023;239(3):362-367. doi: 10.1159/000528968. Epub 2023 Jan 30. Dermatology. 2023. PMID: 36630943 Free PMC article.
179 results